University of Dundee

Philip Cohen recognised for leading contribution to life sciences in Scotland

09 Apr 2009

Sir Philip Cohen was last night given the award for Leading Contribution to Life Sciences in Scotland at the Scottish Enterprise Life Sciences Annual Dinner 2009.

Professor Sir Philip Cohen, Director of the Medical Research Council Protein Phosphorylation Unit and Royal Society Research Professor at the University of Dundee, was recognised for his illustrious career in the life sciences. The award was presented by Cabinet Secretary John Swinney MSP, the Minister of Finance in the Scottish Government in front of more than 700 representatives from the life sciences community in Scotland and worldwide.

Rhona Allison, director of Life Sciences at Scottish Enterprise, said: 'Professor Sir Philip Cohen’s award for Leading Individual Contribution to Life Sciences in Scotland is testament to the ongoing success of the entire life sciences industry in Scotland, both individuals and companies.'

'The industry now comprises of over 620 organisations and contributes over £3 billion to the Scottish economy annually. Scotland has established a strong international reputation based on the quality of its work and opportunities for innovation and collaboration remain, giving this sector room to grow further in 2009. Scottish Enterprise and all those involved will continue to work hard to support a joined up environment where such excellence can prosper.'

Professor Sir Philip Cohen, said: 'I am delighted and honoured to receive this Life Sciences award for my contributions to this field. This award also recognises the extremely high standards and quality of work that is carried out at the Medical Research Council Protein Phosphorylation Unit at the University of Dundee.'

Sir Philip is Director of the Medical Research Council Protein Phosphorylation Unit, and recently received £10 million funding to set up the SCottish Institute for ceLL Signalling (SCILLS) at the University of Dundee, where he has been appointed as its first Director.

He also founded and is the co-Director of the Division of Signal Transduction Therapy (DSTT) at the University of Dundee, which is widely regarded as an exemplary model for the link up between academics and the pharmaceutical industry for which it received a Queen’s Anniversary Prize for Higher and Further Education in 2006. The DSTT is supported by several leading pharmaceutical companies including Pfizer and GlaxoSmithKline.

In 2008 a range of international life sciences companies - working with Scottish Development International -announced plans to create and safeguard 692 jobs in Scotland

Share